Kala Pharmaceuticals Inc (KALA) — Cash Flow-to-Debt Ratio
Kala Pharmaceuticals Inc (KALA) has a Cash Flow-to-Debt Ratio of -1.83x as of March 2026, meaning its operating cash flow of $-4.56 Million could theoretically repay -2% of its total liabilities ($2.49 Million) in one year. Check Kala Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kala Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Kala Pharmaceuticals Inc across 13 annual periods. Also explore Kala Pharmaceuticals Inc (KALA) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Kala Pharmaceuticals Inc (2013–2025)
Year-by-year debt coverage analysis for Kala Pharmaceuticals Inc. For market capitalisation and broader financial context, see Kala Pharmaceuticals Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -12.83x | $-31.99 Million | $2.49 Million | ▼ -1783.8% |
| 2024 | -0.68x | $-29.38 Million | $43.15 Million | ▼ -18.1% |
| 2023 | -0.58x | $-27.93 Million | $48.45 Million | ▲ +50.4% |
| 2022 | -1.16x | $-78.91 Million | $67.85 Million | ▼ -31.8% |
| 2021 | -0.88x | $-108.23 Million | $122.62 Million | ▼ -18.4% |
| 2020 | -0.75x | $-90.69 Million | $121.61 Million | ▼ -0.2% |
| 2019 | -0.74x | $-92.72 Million | $124.63 Million | ▼ -59.4% |
| 2018 | -0.47x | $-54.12 Million | $115.98 Million | ▲ +63.8% |
| 2017 | -1.29x | $-34.10 Million | $26.45 Million | ▼ -532.0% |
| 2016 | -0.20x | $-27.35 Million | $134.09 Million | ▲ +80.8% |
| 2015 | -1.06x | $-15.09 Million | $14.24 Million | ▲ +41.6% |
| 2014 | -1.82x | $-15.36 Million | $8.46 Million | ▼ -15.1% |
| 2013 | -1.58x | $-10.84 Million | $6.87 Million | — |